Cargando…

Another Case of Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy without Other Symptomatic Organ Involvement

Detalles Bibliográficos
Autores principales:	Gillion, Valentine, Devresse, Arnaud, Demoulin, Nathalie, Dahan, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484115/ https://www.ncbi.nlm.nih.gov/pubmed/34622114 http://dx.doi.org/10.1016/j.ekir.2021.07.003

Ejemplares similares

Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy Without Symptomatic Other Organ Involvement
por: Buglioni, Alessia, et al.
Publicado: (2021)

Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1?
por: Gillion, Valentine, et al.
Publicado: (2022)

Mutation in the SLC2A9 Gene: A New Family with Familial Renal Hypouricemia Type 2
por: Maalouli, Christian, et al.
Publicado: (2021)

Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
por: Gillion, Valentine, et al.
Publicado: (2021)

Nephronophthisis Is an Important Differential Diagnosis of Nonspecific Interstitial Nephritis in Adults
por: Gillion, Valentine, et al.
Publicado: (2022)

Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy
por: Buysschaert, Benoit, et al.
Publicado: (2020)

Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
por: Swerdlow, Russell H.
Publicado: (2009)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

Chromium and cobalt intoxication mimicking mitochondriopathy
por: Rattay, Tim W., et al.
Publicado: (2021)

Tubulointerstitial disease in diabetic nephropathy
por: Tonolo, Giancarlo, et al.
Publicado: (2014)

Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018)

Molecular oncology focus - Is carcinogenesis a 'mitochondriopathy'?
por: Czarnecka, Anna M, et al.
Publicado: (2010)

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats
por: Yazdani, Saleh, et al.
Publicado: (2015)

A novel model of adenine-induced tubulointerstitial nephropathy in mice
por: Jia, Ting, et al.
Publicado: (2013)

Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies
por: Shemiakova, Taisiia, et al.
Publicado: (2021)

Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab
por: Demoulin, Nathalie, et al.
Publicado: (2021)

Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies
por: Wilkins, Heather M., et al.
Publicado: (2014)

Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency
por: Bénit, Paule, et al.
Publicado: (2017)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2017)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2018)

Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation
por: Ghaloul-Gonzalez, Lina, et al.
Publicado: (2019)

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
por: Archer, Stephen L., et al.
Publicado: (2022)

SARS-CoV-2 Mitochondriopathy in COVID-19 Pneumonia Exacerbates Hypoxemia
por: Archer, Stephen
Publicado: (2022)

Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2022)

Severe hypercalcaemia early after kidney transplantation in two patients with severe secondary hyperparathyroidism previously treated with etelcalcetide
por: Dachy, Guillaume, et al.
Publicado: (2021)

Recurrence and Outcome of Anti−Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation
por: Coche, Sophie, et al.
Publicado: (2021)

MPC2 variants disrupt mitochondrial pyruvate metabolism and cause an early-onset mitochondriopathy
por: Pujol, Claire, et al.
Publicado: (2022)

Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy
por: Haruhara, Kotaro, et al.
Publicado: (2015)

Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy
por: Verzola, Daniela, et al.
Publicado: (2020)

De Novo Atypical Haemolytic Uremic Syndrome after Kidney Transplantation
por: Devresse, Arnaud, et al.
Publicado: (2018)

Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
por: Koklesova, Lenka, et al.
Publicado: (2021)

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015)

88 Tubulointerstitial nephropathy and uveitis (TINU syndrome): a paediatric case report
por: Mouffouk, Hassan, et al.
Publicado: (2022)

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage
por: Sun, Mengyao, et al.
Publicado: (2023)

Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment
por: Evans, Rhys D. R., et al.
Publicado: (2016)

Three cases of tubulointerstitial nephritis and uveitis syndrome with different clinical manifestations
por: Nagashima, Takamitsu, et al.
Publicado: (2016)

Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD
por: Demoulin, Nathalie, et al.
Publicado: (2021)

Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation
por: Hartmann, Bianca, et al.
Publicado: (2016)

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
por: Haberman, Yael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5u74j4s4v3o0vgb5k2cnvteu4l